Sometimes companies do the bizarrest things...

Why would you make a 4 pack of #fulvestrant?

#OncoPharm #TweetRx #TootRx #bcsm

RT @OncBrothers
#OncTwitter #MedTwitter #LCSM #bcsm #gism #gusm

How are you rationing Carbo?
- Any creative regimens for #BreastCancer (#TNBC or #HER2 pts in neoadj settings)?
- For Cis ineligible small cell #LungCancer? PDL-1 negative mNSCLC?
- Head & Neck Pts?
- How are you sharing this… https://twitter.com/i/web/status/1653848101679931393

Thank you to the #MedTwitter #OncTwitter community - We couldn't have successful #TumorBoardTuesday without your support, encouragement, and engagement!
#LCSM #BCSM #GITwitter #PanCan #GU #HemOnc

RT @marijasullivan
@TumorBoardTues @JenniferLitton 2/18 #TumorBoardTuesday #BCSM @JenniferLitton

🧬 testing returns with BRCA2 path variant
✂️ L mastectomy and ALND
Right risk ⬇️ mastectomy
Found to have 8+/15 LNs
Undergoes adjuvant AC/T

🤔After referring to ☢️ XRT, you discuss which of these treatments?

ET= AI+OS vs Tamoxifen

RT @marijasullivan
@TumorBoardTues @JenniferLitton 2/18 #TumorBoardTuesday #BCSM @JenniferLitton

🧬 testing returns with BRCA2 path variant
✂️ L mastectomy and ALND
Right risk ⬇️ mastectomy
Found to have 8+/15 LNs
Undergoes adjuvant AC/T

🤔After referring to ☢️ XRT, you discuss which of these treatments?

ET= AI+OS vs Tamoxifen

RT @marijasullivan
@TumorBoardTues @JenniferLitton 2/18 #TumorBoardTuesday #BCSM @JenniferLitton

🧬 testing returns with BRCA2 path variant
✂️ L mastectomy and ALND
Right risk ⬇️ mastectomy
Found to have 8+/15 LNs
Undergoes adjuvant AC/T

🤔After referring to ☢️ XRT, you discuss which of these treatments?

ET= AI+OS vs Tamoxifen

RT @marijasullivan
@TumorBoardTues @JenniferLitton 2/18 #TumorBoardTuesday #BCSM @JenniferLitton

🧬 testing returns with BRCA2 path variant
✂️ L mastectomy and ALND
Right risk ⬇️ mastectomy
Found to have 8+/15 LNs
Undergoes adjuvant AC/T

🤔After referring to ☢️ XRT, you discuss which of these treatments?

ET= AI+OS vs Tamoxifen

#breastcancersurvivor #breastcancercare #lifestyle #lifestylemedicine #preventativecare #preventativemedicine #preventativehealth #Prevention #diet #exercise #breastcancerawareness #breastcancersupport #breastcancerfighter #breastcancerresearc #breastcancerawarenessmonth #breastcancerwarrior #triplenegativebreastcancer #clinicalresearch #medicine #MedTwitter #onctwitter #bcsm #survonc #mednewsweek #fda #research #design #design #canada #europe #project #data

#clinicalresearch #survivorship #breastcancersurvivor #breastcancercare #lifestyle #lifestylemedicine #preventativecare #preventativemedicine #preventativehealth #Prevention #diet #exercise #breastcancerawareness #breastcancersupport #breastcancerfighter #breastcancerresearc #breastcancerawarenessmonth #breastcancerwarrior #triplenegativebreastcancer #clinicalresearch #medicine #MedTwitter #onctwitter #bcsm #survonc #mednewsweek #fda #research #design #design #canada #europe #project #data

RT @ADesaiMD
As @HemOncFellows , #bcsm management has become increasingly complex! Below is a #study guide for #MedOnc #MedEd fellows I have been working on :
What do you think? 🧐 @IlanaSchlam @PTarantinoMD @OncBrothers @rleonferre
🛑 #WorkinProgress #NotMedicalAdvice
🙏 #InputsWelcome https://twitter.com/i/web/status/1623657743310626816

RT @Dr_RShatsky
@PTarantinoMD @TumorBoardTues @drsarahsam @Aydah_AlAwadhi @Dr_AmerZeidan @dr_khaledamiri @MariamBird @DrMAttiaE @jobybabyjolly @LeandroJonatad1 @kyutibu @alshamsi2000 @haldhanhani86 @IAbuGhiedaMD @Htyfoor @jamecancerdoc @gandhi_shipra @RayMacCuUladh @draalicefrancis @sflomos @JenniferPlichta @Marie_Tsvetkova So who will win when push comes to shove in the PIK3CA pathway -alpelisib or capivasertib #tumorboardtuesday #bcsm

RT @PTarantinoMD
@TumorBoardTues @drsarahsam 2/24 #TumorBoardTuesday #BCSM

☢️Jan ‘11: TC x 4 ➡️ XRT
Treatment well tolerated, apart from alopecia, G2 fatigue

Summer ‘11 – started letrozole
🔀 Fall ‘11 – switch to exemestane due to G3 arthralgias ➡️ improvement of symptoms

2016 completed 5 years of Aromatase Inhibitor

RT @PTarantinoMD
@TumorBoardTues @drsarahsam 3/24 #TumorBoardTuesday #BCSM

Apr ‘21 – Mild abdo discomfort
🩻CT CAP scan:
liver: 5 lesions, max 15 mm
bone: spine & ribs
enlarged mediastinal lymph nodes
🩸: G1 anemia, normal LFTs, no other abnormality

🔬US-guided liver biopsy:
IDC, grade 2, ER 90%, PR 0%, HER2-0, Ki67 25%

RT @PTarantinoMD
@TumorBoardTues @drsarahsam 9/24 #TumorBoardTuesday #BCSM
👩🏻‍🏫Mini tweetorial 2👨🏻‍🏫

📌Adjuvant abemaciclib - CDK4/6 inhibitor

📍Tested in monarchE phase 3 trial
📍Last update of the study: 2 years of adjuvant abema added to ET led to ⬇️ by 33% in risk of recurrence compared with adjuvant ET alone

RT @PTarantinoMD
@TumorBoardTues @drsarahsam 10/24 #TumorBoardTuesday #BCSM
👩🏻‍🏫Mini tweetorial 3👨🏻‍🏫

📌Adjuvant Palbociclib - CDK4/6 inhibitor

📍Tested in the adjuvant setting
📍Failed to improve outcomes in 2 phase 3 trials (✨PALLAS & ✨PENELOPE-B).
📍Phase 3 trial of adjuvant ribociclib ongoing (✨NATALEE)
✍🏼

RT @Dr_RShatsky
@PTarantinoMD @TumorBoardTues @drsarahsam @Aydah_AlAwadhi @Dr_AmerZeidan @dr_khaledamiri @MariamBird @DrMAttiaE @jobybabyjolly @LeandroJonatad1 @kyutibu @alshamsi2000 @haldhanhani86 @IAbuGhiedaMD @Htyfoor @jamecancerdoc @gandhi_shipra @RayMacCuUladh @draalicefrancis @sflomos @JenniferPlichta @Marie_Tsvetkova So who will win when push comes to shove in the PIK3CA pathway -alpelisib or capivasertib #tumorboardtuesday #bcsm

RT @TumorBoardTues
📢 Join this #TumorBoardTuesday dynamic duo!!

🥼@drsarahsam @PTarantinoMD take us through CDK 4/6 inhibitor in #BreastCancer

👇🏽Join us!👇🏽

📱Weigh in your answer
🧾Bring receipts
🙋Ask Q’s
📊check polls
🔁RT
👩🏻‍⚕️tag peers👨🏻‍⚕️
@MPishvaian @JohnEbbenMDPhD
#medtwitter #BCSM https://twitter.com/PTarantinoMD/status/1630734693619343361

RT @PTarantinoMD
@TumorBoardTues @drsarahsam 2/24 #TumorBoardTuesday #BCSM

☢️Jan ‘11: TC x 4 ➡️ XRT
Treatment well tolerated, apart from alopecia, G2 fatigue

Summer ‘11 – started letrozole
🔀 Fall ‘11 – switch to exemestane due to G3 arthralgias ➡️ improvement of symptoms

2016 completed 5 years of Aromatase Inhibitor

RT @PTarantinoMD
@TumorBoardTues @drsarahsam 3/24 #TumorBoardTuesday #BCSM

Apr ‘21 – Mild abdo discomfort
🩻CT CAP scan:
liver: 5 lesions, max 15 mm
bone: spine & ribs
enlarged mediastinal lymph nodes
🩸: G1 anemia, normal LFTs, no other abnormality

🔬US-guided liver biopsy:
IDC, grade 2, ER 90%, PR 0%, HER2-0, Ki67 25%

RT @PTarantinoMD
@TumorBoardTues @drsarahsam 2/24 #TumorBoardTuesday #BCSM

☢️Jan ‘11: TC x 4 ➡️ XRT
Treatment well tolerated, apart from alopecia, G2 fatigue

Summer ‘11 – started letrozole
🔀 Fall ‘11 – switch to exemestane due to G3 arthralgias ➡️ improvement of symptoms

2016 completed 5 years of Aromatase Inhibitor